Mechanisms in AIT: Insights 2021
暂无分享,去创建一个
[1] J. Subiza,et al. Allergoid‐mannan conjugates imprint tolerogenic features in human macrophages , 2021, Allergy.
[2] C. Akdis,et al. Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming , 2021, Mucosal immunology.
[3] Da Huo,et al. A Dendritic Cells-Targeting Nano-Vaccine by Coupling Polylactic-Co-Glycolic Acid-Encapsulated Allergen with Mannan Induces Regulatory T Cells , 2021, International Archives of Allergy and Immunology.
[4] S. Sánchez-Ramón,et al. Editorial: Trained Immunity-Based Vaccines , 2021, Frontiers in Immunology.
[5] S. Durham,et al. The role of allergen‐specific IgE, IgG and IgA in allergic disease , 2021, Allergy.
[6] A. Togias,et al. Differential Induction of Allergen-specific IgA Responses following Timothy Grass Subcutaneous and Sublingual Immunotherapy. , 2021, The Journal of allergy and clinical immunology.
[7] M. Akdiş,et al. Regulatory B cells, A to Z , 2021, Allergy.
[8] Feng Q. He,et al. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. , 2021, Immunity.
[9] I. Pali-Schöll,et al. Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience. , 2021, The journal of allergy and clinical immunology. In practice.
[10] M. Akdiş,et al. B regulatory cells in allergy , 2020, Immunological reviews.
[11] H. Oettgen,et al. IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy , 2020, Frontiers in Immunology.
[12] S. Boyd,et al. Biology and dynamics of B cells in the context of IgE‐mediated food allergy , 2020, Allergy.
[13] U. Jappe,et al. Trained immunity and allergy: State of the art and future perspectives , 2020, Allergy.
[14] C. Akdis,et al. Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy. , 2020, The Journal of allergy and clinical immunology.
[15] P. Tassinari,et al. Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs , 2020, European Respiratory Journal.
[16] M. Akdiş,et al. Tolerance mechanisms of allergen immunotherapy , 2020 .
[17] R. Dahl,et al. Basophil sensitivity reflects long‐term clinical outcome of subcutaneous immunotherapy in grass pollen‐allergic patients , 2020, Allergy.
[18] M. V. van Zelm,et al. Induction of IgG2 and IgG4 B‐cell memory following sublingual immunotherapy for ryegrass pollen allergy , 2019, Allergy.
[19] E. Fernández‐Caldas,et al. Alum impairs tolerogenic properties induced by allergoid‐mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs , 2019, Allergy.
[20] G. Nilsson,et al. Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid. , 2019, The Journal of allergy and clinical immunology.
[21] C. Akdis,et al. Der p 1‐specific regulatory T‐cell response during house dust mite allergen immunotherapy , 2019, Allergy.
[22] S. Durham,et al. Nasal allergen‐neutralizing IgG4 antibodies block IgE‐mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy , 2019, The Journal of allergy and clinical immunology.
[23] C. Akdis,et al. Role of Der p 1–specific B cells in immune tolerance during 2 years of house dust mite–specific immunotherapy , 2019, The Journal of allergy and clinical immunology.
[24] F. Alessandrini,et al. IL‐10 signaling in dendritic cells is required for tolerance induction in a murine model of allergic airway inflammation , 2019, European journal of immunology.
[25] M. Pybus,et al. Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin‐9 and CD44 , 2018, Immunity.
[26] M. Akdiş,et al. Mechanisms of allergen-specific immunotherapy: Diverse mechanisms of immune tolerance to allergens. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[27] O. Palomares,et al. Novel vaccines targeting dendritic cells by coupling allergoids to mannan , 2018, Allergo Journal International.
[28] Allon M Klein,et al. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR , 2018, Nature Immunology.
[29] B. Cases,et al. Oral myeloid cells uptake allergoids coupled to mannan driving Th1/Treg responses upon sublingual delivery in mice , 2018, Allergy.
[30] Zhiheng Xu,et al. Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation , 2017, Cell.
[31] K. Ruxrungtham,et al. High‐dose bee venom exposure induces similar tolerogenic B‐cell responses in allergic patients and healthy beekeepers , 2017, Allergy. European Journal of Allergy and Clinical Immunology.
[32] M. Akdiş,et al. Role of IgG4 in IgE-mediated allergic responses. , 2016, The Journal of allergy and clinical immunology.
[33] P. Reche,et al. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1. , 2016, The Journal of allergy and clinical immunology.
[34] C. Akdis,et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. , 2013, The Journal of allergy and clinical immunology.
[35] D. Isenberg,et al. Lipid-Antigen Presentation by CD1d+ B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells , 2012, Immunity.
[36] S. Durham,et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3‐expressing cells and elevated allergen‐specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E‐facilitated allergen binding to B cells , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[37] Trained Immunity-based Vaccines , 2021, Frontiers Research Topics.
[38] S. Durham,et al. Allergen immunotherapy and tolerance. , 2013, Allergology international : official journal of the Japanese Society of Allergology.
[39] Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience , 2022, The Journal of Allergy and Clinical Immunology: In Practice.